- Home
- WAI vs FGEN Comparison
WAI vs FGEN Comparison
Compare WAI & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAI
- FGEN
- Stock Information
- Founded
- WAI 2018
- FGEN 1993
- Country
- WAI China
- FGEN United States
- Employees
- WAI N/A
- FGEN N/A
- Industry
- WAI
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- WAI
- FGEN Health Care
- Exchange
- WAI NYSE
- FGEN Nasdaq
- Market Cap
- WAI 8.1M
- FGEN 33.5M
- IPO Year
- WAI 2023
- FGEN 2014
- Fundamental
- Price
- WAI $0.43
- FGEN $7.58
- Analyst Decision
- WAI
- FGEN Strong Buy
- Analyst Count
- WAI 0
- FGEN 1
- Target Price
- WAI N/A
- FGEN $250.00
- AVG Volume (30 Days)
- WAI 1.8M
- FGEN 65.9K
- Earning Date
- WAI 08-24-2025
- FGEN 08-05-2025
- Dividend Yield
- WAI N/A
- FGEN N/A
- EPS Growth
- WAI N/A
- FGEN N/A
- EPS
- WAI N/A
- FGEN N/A
- Revenue
- WAI $3,750,352.00
- FGEN $6,996,000.00
- Revenue This Year
- WAI N/A
- FGEN N/A
- Revenue Next Year
- WAI N/A
- FGEN N/A
- P/E Ratio
- WAI N/A
- FGEN N/A
- Revenue Growth
- WAI N/A
- FGEN N/A
- 52 Week Low
- WAI $0.41
- FGEN $4.50
- 52 Week High
- WAI $20.00
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- WAI N/A
- FGEN 59.10
- Support Level
- WAI N/A
- FGEN $7.03
- Resistance Level
- WAI N/A
- FGEN $5.73
- Average True Range (ATR)
- WAI 0.00
- FGEN 0.52
- MACD
- WAI 0.00
- FGEN 0.30
- Stochastic Oscillator
- WAI 0.00
- FGEN 85.45
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.